Advertisement

Bivalent Diabodies

  • Roland E. KontermannEmail author
Protocol
  • 1.9k Downloads
Part of the Springer Protocols Handbooks book series (SPH)

Abstract

Single-chain Fv fragments exhibiting monovalent binding can be converted into bivalent molecules by reducing the linker connecting the two variable domains to approximately five residues resulting in homodimerization of two polypeptide chains. This protocol describes the cloning steps to convert an scFv into a diabody molecule and provides some information for production and analysis.

Keywords

Antibody Fragment SacI Site Calf Intestine Alkaline Phosphatase Antibody Sequence Restriction Site Analysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Alfthan K, Takkinen K, Sizmann D, Söderlund H, Teeri TT (1995) Properties of a single-chain antibody containing different linker peptides. Protein Eng 8:725–731PubMedCrossRefGoogle Scholar
  2. Desplancq D, King DJ, Lawson ADG, Mountain A (1994) Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3. Protein Eng 8:1027–1033CrossRefGoogle Scholar
  3. FitzGerald K, Holliger P, Winter G (1997) Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastoris. Protein Eng 10:1221–1225PubMedCrossRefGoogle Scholar
  4. Holliger P, Prospero T, Winter G (1993) “Diabodies”: small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA 90:6444–6448PubMedCrossRefGoogle Scholar
  5. Kim YJ, Meelamegam R, Heo MA, Edwardraja S, Paik HJ, Lee SG (2008) Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains. J Microbiol Biotechnol 18:1186–1190PubMedGoogle Scholar
  6. Kontermann RE, Martineau P, Cummings CE, Karpas A, Allen D, Derbyshire E, Winter G (1997) Enzyme immunoassays using bispecific diabodies. Immunotechnology 3:137–144PubMedCrossRefGoogle Scholar
  7. Kortt A, Lah M, Oddie GW, Gruen CL, Burns JE, Pearce LA, Atwell JL, McCoy AK, Howlett GJ, Metzger DW, Webster RG, Hudson PJ (1997) Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer. Protein Eng 10:423–433PubMedCrossRefGoogle Scholar
  8. Le Gall F, Kipriyanov SM, Moldenhauer G, Little M (1999) Di, tri and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding. FEBS Lett 453:164–168PubMedCrossRefGoogle Scholar
  9. Perisic O, Webb PA, Holliger P, Winter G, Williams RL (1994) Crystal structure of a diabody, a bivalent antibody fragment. Structure 2:1217–1226PubMedCrossRefGoogle Scholar
  10. Power BE, Ivancic N, Harley VR, Webster RG, Kortt AA, Irving RA, Hudson PJ (1992) High-level temperature-induced synthesis of an antibody VH domain in Escherichia coli using the PelB secretion signal. Gene 113:95–99PubMedCrossRefGoogle Scholar
  11. Wu AM, Yazaki PJ (2000) Designer genes: recombinant antibody fragments for biological imaging. Q J Nucl Med 44:268–283PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Institut für Zellbiologie und ImmunologieUniversität StuttgartStuttgartGermany

Personalised recommendations